Londamocitinib

CAS No. 2241039-81-4

Londamocitinib( —— )

Catalog No. M32971 CAS No. 2241039-81-4

Londamocitinib (JAK1-IN-7) is a selective and potent JAK1 inhibitor with anti-inflammatory activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 567 In Stock
5MG 440 In Stock
10MG 598 In Stock
25MG 905 In Stock
50MG 1144 In Stock
100MG 1535 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Londamocitinib
  • Note
    Research use only, not for human use.
  • Brief Description
    Londamocitinib (JAK1-IN-7) is a selective and potent JAK1 inhibitor with anti-inflammatory activity.
  • Description
    Londamocitinib (AZD4604; JAK1-IN-7) is a Janus-associated kinase 1 (JAK1) inhibitor extracted from patent WO2018134213A1, Example 63, has an anti-inflammatory effect.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    JAK
  • Recptor
    JAK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2241039-81-4
  • Formula Weight
    599.65
  • Molecular Formula
    C28H31F2N7O4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 71.43 mg/mL (119.12 mM; Ultrasonic )
  • SMILES
    COC[C@@H](N1CCN(C)CC1)C(=O)Nc1cccc2c(c[nH]c12)-c1nc(Nc2cccc(c2F)S(C)(=O)=O)ncc1F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. NILSSON, Karl, Magnus, et al. Jak1 selective inhibitors. WO2018134213A1.
molnova catalog
related products
  • WYE-151650

    WYE-151650 is a novel potent, selective JAK3 inhibitor with IC50 of 0.8 nM, displays 36-, 14-, and 34-fold selectivity against JAK-1, JAK-2, and Tyk-2, respectively.

  • JAK-IN-5 hydrochlori...

    JAK-IN-5 hydrochloride is an inhibitor of JAK.

  • AZ960

    A potent, selective JAK2 inhibitor with Ki of 0.45 nM, IC50 of <3 nM.